Gujarat Themis Biosyn Intrinsic Value
Gujarat Themis Biosyn (GUJTHEM) median intrinsic value is ₹301.82 from 9 valuation models (range ₹108–₹901), vs current price ₹360.50 — -16.3% downside (Trading Above Median Value), margin of safety -19.4%. Read GUJTHEM dividend payout details for the complete payout history and dividend yield track record.
GUJTHEM Valuation Methods Summary — DCF, Graham Number & P/E
Gujarat Themis Biosyn intrinsic value across 9 models vs current price ₹360.50 — upside/downside and value range per method. For current market price and key ratios, visit Gujarat Themis Biosyn share price chart.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹108.15 | ₹86.52 - ₹129.78 | -70.0% | EPS: ₹4.28, Sector P/E: 22x |
| Book Value Method | asset | ₹523.64 | ₹471.28 - ₹576.00 | +45.3% | Book Value/Share: ₹261.82, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹301.82 | ₹271.64 - ₹332.00 | -16.3% | Revenue/Share: ₹150.91, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹690.91 | ₹621.82 - ₹760.00 | +91.7% | EBITDA: ₹76.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹901.25 | ₹721.00 - ₹1081.50 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹108.15 | ₹97.34 - ₹118.97 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹108.15 | ₹97.34 - ₹118.97 | -70.0% | Revenue Growth: 8.7%, Adj P/E: 15.7x |
| ROE Based Valuation | profitability | ₹649.09 | ₹584.18 - ₹714.00 | +80.1% | ROE: 17.7%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹158.79 | ₹142.91 - ₹174.67 | -56.0% | EPS: ₹4.28, BVPS: ₹261.82 |
GUJTHEM Intrinsic Value vs Market Price — All Valuation Models
Gujarat Themis Biosyn fair value range ₹108–₹901 vs current market price ₹360.50 across 9 valuation models. Analyse Gujarat Themis Biosyn ownership pattern to track promoter, FII and institutional holdings.
GUJTHEM Intrinsic Value Analysis — Undervalued or Overvalued?
Gujarat Themis Biosyn median intrinsic value ₹301.82, current price ₹360.50 — Trading Above Median Value by 16.3%, margin of safety -19.4%.
What is the intrinsic value of GUJTHEM?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Gujarat Themis Biosyn (GUJTHEM) is ₹301.82 (median value). With the current market price of ₹360.50, this represents a -16.3% variance from our estimated fair value.
The valuation range spans from ₹108.15 to ₹901.25, indicating ₹108.15 - ₹901.25.
Is GUJTHEM undervalued or overvalued?
Based on our multi-method analysis, Gujarat Themis Biosyn (GUJTHEM) appears to be trading above median value by approximately 16.3%.
GUJTHEM Financial Health — Key Ratios vs Industry Benchmarks
Gujarat Themis Biosyn financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.65 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 17.7% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 46.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.33x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
GUJTHEM Cash Flow Quality — Operating & Free Cash Flow
Gujarat Themis Biosyn operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹91 Cr | ₹35 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹64 Cr | ₹37 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹40 Cr | ₹30 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹40 Cr | ₹25 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹11 Cr | ₹10 Cr | Positive Free Cash Flow | 8/10 |